Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and CholangiocarcinomaSummary

Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and CholangiocarcinomaSummary

Primary liver cancer (PLC) includes hepatocellular carcinoma and intrahepatic cholangiocarcinoma and is the sixth most common cancer worldwide with poor prognosis. PLC is characterized by an abundant stromal reaction in which cancer-associated fibroblasts (CAFs) are one of the major stromal componen...

Full description

Bibliographic Details
Main Authors:	Fan Ying, Mandy Sze Man Chan, Terence Kin Wah Lee
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Cellular and Molecular Gastroenterology and Hepatology
Subjects:	Primary Liver Cancer Hepatocellular Carcinoma Cancer-Associated Fibroblasts Cholangiocarcinoma Origin Immune Suppression
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352345X23000061

Similar Items

Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach
by: Joon Hyuk Choi, et al.
Published: (2022-07-01)

Role of Chemokines in the Biology of Cholangiocarcinoma
by: Alessandra Caligiuri, et al.
Published: (2020-08-01)

Association between high expression of intratumoral fibroblast activation protein and survival in patients with intrahepatic cholangiocarcinoma
by: Yuhei Waki, et al.
Published: (2023-11-01)

Heterogeneity of Cholangiocarcinoma Immune Biology
by: Francesca Vita, et al.
Published: (2023-03-01)

Cancer-Associated Fibroblasts in Cholangiocarcinoma: Current Knowledge and Possible Implications for Therapy
by: Michele Montori, et al.
Published: (2022-11-01)

Double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma
by: Yi-Hsuan Hu, et al.
Published: (2020-01-01)

Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
by: Yingpinyapat Kittirat, et al.
Published: (2022-08-01)

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma
by: Matteo Renzulli, et al.
Published: (2021-07-01)

Liver Transplantation for Incidental Cholangiocarcinoma or Combined Hepatocellular Carcinoma/Cholangiocarcinoma—Own Experiences and Review of the Literature
by: Laura Schwenk, et al.
Published: (2023-07-01)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
by: Jennifer Sammon, et al.
Published: (2018-02-01)

Mixed Hepatocellular Cholangiocarcinoma: A Comparison of Survival between Mixed Tumors, Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma from a Single Center
by: Lea Penzkofer, et al.
Published: (2023-01-01)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
by: Timo Alexander Auer, et al.
Published: (2023-05-01)

Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse
by: Suyanee Thongchot, et al.
Published: (2021-04-01)

Contrast-enhanced ultrasound imaging features and clinical characteristics of combined hepatocellular cholangiocarcinoma: comparison with hepatocellular carcinoma and cholangiocarcinoma
by: Hai-Chun Zhang, et al.
Published: (2020-10-01)

Isolation of cancer‐associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma
by: Meng Sha, et al.
Published: (2018-09-01)

Combined hepatocellular cholangiocarcinoma in hepatectomy specimens: A clinicopathologic analysis
by: Nayana Patil, et al.
Published: (2023-01-01)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
by: Sang Jae Noh, et al.
Published: (2012-12-01)

Liver transplantation versus resection for patients with combined hepatocellular cholangiocarcinoma: A retrospective cohort study
by: Shizheng Mi, et al.
Published: (2023-10-01)

Surgical Strategies for Combined Hepatocellular-Cholangiocarcinoma (cHCC-CC)
by: Marcus Bahra, et al.
Published: (2023-01-01)

Isolation and characterization of cancer-associated fibroblasts in the tumor microenvironment of hepatocellular carcinoma
by: Kyoungdo Mun, et al.
Published: (2023-09-01)

Cancer-associated fibroblasts induce sorafenib resistance of hepatocellular carcinoma cells through CXCL12/FOLR1
by: Jiali Zhao, et al.
Published: (2023-12-01)

Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept
by: Hanna Hong, et al.
Published: (2024-02-01)

Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults
by: In Rae Cho, et al.
Published: (2022-03-01)

The prognostic relationship between histopathological and immunohistochemical features of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and mixed type
by: Fatmagül Çabuk, et al.
Published: (2020-07-01)

Stereotactic Body Radiation Therapy (SBRT) Plus Immune Checkpoint Inhibitors (ICI) in Hepatocellular Carcinoma and Cholangiocarcinoma
by: Joanna Jiang, et al.
Published: (2022-12-01)

Deep Learning for the Pathologic Diagnosis of Hepatocellular Carcinoma, Cholangiocarcinoma, and Metastatic Colorectal Cancer
by: Hyun-Jong Jang, et al.
Published: (2023-11-01)

Identifying cancer-associated fibroblasts as emerging targets for hepatocellular carcinoma
by: Jie Zhang, et al.
Published: (2020-10-01)

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells
by: Penkhae Utaijaratrasmi, et al.
Published: (2018-01-01)

The expression of tumor progression markers in hepatocellular and cholangiocellular liver carcinomas of different sizes
by: V. A. Tumanskiy, et al.
Published: (2015-08-01)

Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
by: Alexander A. Azizi, et al.
Published: (2020-09-01)

Preoperative differentiation of hepatocellular carcinoma with peripheral rim-like enhancement from intrahepatic mass-forming cholangiocarcinoma on contrast-enhanced MRI
by: Sisi Zhang, et al.
Published: (2022-11-01)

Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma
by: Tian MX, et al.
Published: (2019-06-01)

Synchronous Hepatocellular Carcinoma and Cholangiocarcinoma in a Patient Transplanted for Cryptogenic Cirrhosis
by: B Geramizadeh, et al.
Published: (2014-07-01)

Emerging Role of Cancer-Associated Fibroblasts in Progression and Treatment of Hepatocellular Carcinoma
by: Hikmet Akkız
Published: (2023-02-01)

Intrahepatic cholangiocarcinoma: Tumour heterogeneity and its clinical relevance
by: Mina Komuta
Published: (2022-07-01)

Transarterial Radioembolization of Hepatocellular Carcinoma, Liver-Dominant Hepatic Colorectal Cancer Metastases, and Cholangiocarcinoma Using Yttrium90 Microspheres: Eight-Year Single-Center Real-Life Experience
by: Julie Pellegrinelli, et al.
Published: (2021-01-01)

Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine
by: Riccardo Carloni, et al.
Published: (2022-11-01)

Intrahepatic cholangiocarcinoma mimicking a liver abscess
by: Haythem Yacoub, et al.
Published: (2020-12-01)

The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma—State of the Art and Future Perspectives
by: Johannes Eschrich, et al.
Published: (2023-01-01)

Characterization of cancer-related fibroblasts (CAF) in hepatocellular carcinoma and construction of CAF-based risk signature based on single-cell RNA-seq and bulk RNA-seq data
by: Lianghe Yu, et al.
Published: (2022-09-01)